On 09 September, Horsehead Holding Corp. (NASDAQ:ZINC) shares moved down -2.64% and was closed at $7.38. ZINC EPS growth in last 5 year was 16.30%. Horsehead Holding Corp. (NASDAQ:ZINC) year to date (YTD) performance is -53.38%.
Horsehead Holding Corp. is a producer of zinc and nickel-based products sold primarily to customers throughout the United States of America and Canada. The Company is also a recycler of electric arc furnace (EAF) dust in the United States and a recycler of hazardous and non-hazardous waste for the specialty steel industry.
On 1 September, Horsehead Holding Corp. (NASDAQ:ZINC) issued an update on operations at its Mooresboro, North Carolina zinc production facility. The Company reported that the facility produced approximately 3,200 tons of zinc metal in August, bringing the quarter-to-date production to over 7,000 tons after two months. Production in August was limited by two primary factors: (1) equipment downtime primarily related to plugging of lines carrying feedstock, gypsum and lime which forced us to idle the plant for several days while these issues were being addressed and (2) lower than expected current efficiency in the cell house which resulted in reduced production for a given power input. Modifications were made to reduce the frequency of the plugging issues and the current efficiency improved during the month and is expected to continue to improve in September.
GigOptix, Inc. (NYSEMKT:GIG) shares increased 1.60% in last trading session and ended the day at $1.90. GIG Gross Margin is 60.40% and its has a return on assets of -4.20%. GigOptix, Inc. (NYSEMKT:GIG) quarterly performance is 28.38%.
GigOptix, Inc. (GigOptix) is a fabless supplier of semiconductor and optical components that enable high-speed end-to-end information streaming over the network and address emerging high-growth opportunities in the communications, industrial, defense and avionics industries. The business is made up of two product lines: the High-Speed Communications (HSC) product line and the Industrial product line. The Company offers an array of high performance MMIC solutions that enable next generation wireless microwave systems up to 90GHz and drivers, TIAs and TFPS optical modulators for 40G and 100G fiber-optic telecommunications and data-communications networks. It also offers a wide range of digital and mixed-signal ASIC solutions.
On 1 September, GigOptix, Inc. (NYSEMKT:GIG) announced the inception of the Global Customer Operations Organization (GCO), under the leadership of Dr. Raluca Dinu, Executive Vice President of Global Sales and Marketing. This change in organization structure is aimed at establishing complete alignment of the company’s operations with the customers’ requirements, by integrating into one organization the driving of a strategic roadmap, tactical and product marketing, engineering applications, and global sales.
CytRx Corporation (NASDAQ:CYTR) caters to the Healthcare space. Its weekly performance is 13.54%. On the last day of trading company shares ended up $2.60. CytRx Corporation (NASDAQ:CYTR) distance from 50-day simple moving average (SMA50) is -10.31%.
CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The company is focused on the clinical development of aldoxorubicin, its modified version of a chemotherapeutic agent. Aldoxorubicin is a conjugate of the commonly prescribed chemotherapeutic agent doxorubicin that binds to circulating albumin in the bloodstream and is concentrated at the site of tumors. It consists of (6-Maleimidocaproyl) hydrazine, an acid-sensitive molecule that is conjugated to doxorubicin.
CytRx Corporation (NASDAQ:CYTR) announced that the Phase 2b clinical trial design of its clinical trial in small-cell lung cancer (SCLC) will be presented in the P3.07 Poster Session on SCLC at the 16th World Conference on Lung Cancer in Denver, Colorado, September 6 – 9, 2015.
Xerox Corporation (NYSE:XRX) shares moved down -1.82% in last trading session and ended the day at $10.23. XRX Gross Margin is 33.10% and its has a return on assets of 2.30%. Xerox Corporation (NYSE:XRX) quarterly performance is -8.57%.
Xerox Corporation is engaged in offering business process and document management solutions. The Company operates through the following segments: Services, Document Technology and Other. The Company’s customers include small and midsize businesses (SMBs), graphic communications companies, Governmental entities, educational institutions and Fortune 1000 corporate accounts. The Company’s Services segment provides two types of service offerings: Business Process Outsourcing (BPO) and Document Outsourcing (DO).
On 1 September, Xerox Corporation (NYSE:XRX) said that, it has acquired a Massachusetts-based company that helps pharmaceutical companies minimize or eliminate financial and reimbursement hurdles for patients.
CAS Medical Systems Inc. (NASDAQ:CASM) caters to the Healthcare space. It has a net profit margin of -35.70% and weekly performance is -2.56%. On the last day of trading company shares ended up $1.14. CAS Medical Systems Inc. (NASDAQ:CASM) distance from 50-day simple moving average (SMA50) is -2.98%.
CAS Medical Systems, Inc. (CASMED) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that are vital to patient care. The Company’s products include the FORE-SIGHT and FORE-SIGHT ELITE Absolute Tissue Oximeters and sensors and its traditional monitoring products, which include MAXNIBP and MAXIQ blood pressure measurement technologies, monitoring products for the bedside and out-patient oral surgery settings, including the 740 SELECT and PPM3 monitors, and neonatal vital signs supplies.
CAS Medical Systems Inc. (NASDAQ:CASM) was upgraded by Zacks from a “hold” rating to a “buy” rating in a report issued on Monday, MarketBeat.com reports. The brokerage presently has a $1.25 target price on the medical technology company’s stock. Zacks‘s target price points to a potential upside of 8.70% from the stock’s current price.
Leave a Reply